Koji Kato

26PUBLICATIONS
71CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Medical biotechnology diagnostics (incl. biosensors)Cardiovascular medicine and haematology not elsewhere classifiedHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Aug 12, 2026
Quizartinib Resistance Mutations and Treatment Outcomes in Relapsed or Refractory FLT3-ITD-Positive AML.

|Jul 24, 2026
Real-World Safety and Efficacy of Pola-R-CHP in Previously Untreated DLBCL: POLASTAR Interim Analysis of 500 Patients.

|Jul 23, 2026
Early prediction of ICANS using CRS characteristics in B-cell lymphoma patients receiving CAR-T therapy.

|Jan 03, 2026
Safety and effectiveness of lisocabtagene maraleucel following PD-1 blockade in relapsed or refractory PMBCL.

Kohei Yamaguchi, Takuji Yamauchi, Seiya Hirakawa

|Nov 26, 2025
Long-term follow-up of belumosudil as second or subsequent line of therapy for steroid-dependent/resistant cGVHD: clinical outcomes from a Japanese study.

Koji Kato, Yoshihiro Inamoto, Toshiro Kawakita

|Mar 11, 2025
Indirect presentation of mismatched human leukocyte antigen-B associates with outcomes of cord blood transplantation.

Takeshi Sugio, Kohta Miyawaki, Naoyuki Uchida

Pageof 5

Frequent Collaborators

6 joint publications

Koji Izutsu

3 joint publications

Momoko Nishikori

2 joint publications

Makoto Yoshimitsu

2 joint publications

Kohta Miyawaki